Elements | Concentration levels a | Controls | CHDs Cases | cOR (95% CI) | aOR (95% CI)b |
---|---|---|---|---|---|
No. (%) | No. (%) | ||||
MiBP | First-tertile | 90(33.58%) | 82(33.47%) | Reference | Reference |
 | Second-tertile | 87(32.46%) | 85(34.69%) | 1.07(0.70–1.64) | 1.04(0.65–1.67) |
 | Third-tertile | 91(33.96%) | 78(31.84%) | 0.94(0.62–1.44) | 0.87(0.54–1.41) |
MnBP | First-tertile | 96(35.82%) | 76(31.02%) | Reference | Reference |
 | Second-tertile | 94(35.07%) | 76(31.02%) | 1.02(0.67–1.57) | 1.14(0.69–1.79) |
 | Third-tertile | 78(29.10%) | 93(37.96%) | 1.51(0.98–2.31) | 1.48(0.92–2.38) |
MBzP | First-tertile | 81(30.22%) | 85(34.69%) | Reference | Reference |
 | Second-tertile | 98(36.57%) | 78(31.84%) | 0.76(0.50–1.16) | 0.75(0.46–1.21) |
 | Third-tertile | 89(33.21%) | 82(33.47%) | 0.88(0.57–1.35) | 0.93(0.58–1.51) |
MEHP | First-tertile | 81(30.22%) | 90(36.73%) | Reference | Reference |
 | Second-tertile | 88(32.84%) | 83(33.88%) | 0.85(0.56–1.30) | 0.67(0.41–1.08) |
 | Third-tertile | 99(36.94%) | 72(29.39%) | 0.66(0.43-1.00) | 0.63(0.39–1.02) |
MEHHP | First-tertile | 92(34.33%) | 79(32.24%) | Reference | Reference |
 | Second-tertile | 94(35.07%) | 75(30.61%) | 0.93(0.61–1.42) | 0.76(0.47–1.23) |
 | Third-tertile | 82(30.60%) | 91(37.14%) | 1.29(0.85–1.97) | 1.25(0.77–2.01) |
MEOHP | First-tertile | 93(34.7%) | 77(31.43%) | Reference | Reference |
 | Second-tertile | 90(33.58%) | 85(34.69%) | 1.14(0.75–1.74) | 0.90(0.56–1.45) |
 | Third-tertile | 85(31.72%) | 83(33.88%) | 1.18(0.77–1.81) | 1.09(0.68–1.77) |
MECPP | First-tertile | 94(35.07%) | 76(31.02%) | Reference | Reference |
 | Second-tertile | 86(32.09%) | 85(34.69%) | 1.22(0.80–1.87) | 0.98(0.61–1.59) |
 | Third-tertile | 88(32.84%) | 84(34.29%) | 1.18(0.77–1.81) | 1.01(0.62–1.64) |
MCMHP | First-tertile | 85(31.72%) | 82(33.47%) | Reference | Reference |
 | Second-tertile | 100(37.31%) | 74(30.2%) | 0.77(0.50–1.18) | 0.70(0.43–1.15) |
 | Third-tertile | 83(30.97%) | 89(36.33%) | 1.11(0.73–1.70) | 1.12(0.69–1.81) |